tirzepatide or semaglutide for weight loss vs Tirzepatide vs. Semaglutide: Which Weight

this risks contaminating a sterile preparation and is not a reliable or standard quality check for parenteral medicines

Though more extensive research is still needed, a study conducted by Novo Nordisk over four years suggests that Wegovy is safe for long-term use

Patients in the intervention group who lost 10% of their body weight showed significant improvements in FIQ scores and reduced tender point counts, even in upper body sites like the trapezius, suggesting weight loss has benefits beyond just unloading mechanical joints

Additionally, weight loss typically plateaus after several months of treatment, and patients may interpret this natural stabilization as medication failure